1. OC-0493: Head and neck cancer HPV16 variant analysis, HPV E2 variations and E2 protein disruption as radiation sensitivity biomarker. (April 2015) Authors: Blakaj, D.; Walston, S.; Chen, Z.; Garg, M.; Guha, C.; Kalnicki, S.; Smith, R.V.; Burk, R.D.; Schlecht, N.F.; Kumar, B.; Old, M.; Teknos, T.; Chakravarti, A. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0331: Cetuximab versus Platinum-based Chemoradiation in Locally Advanced p16 Positive Oropharyngeal Cancer. (May 2017) Authors: Barney, C.; Walston, S.; Zamora, P.; Nolan, N.; Diavolitsis, V.; Blakaj, D.; Wobb, J.; Mitchell, D.; Grecula, J.; Savvides, P.; Bhatt, A. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗